JP2021505527A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505527A5
JP2021505527A5 JP2020521460A JP2020521460A JP2021505527A5 JP 2021505527 A5 JP2021505527 A5 JP 2021505527A5 JP 2020521460 A JP2020521460 A JP 2020521460A JP 2020521460 A JP2020521460 A JP 2020521460A JP 2021505527 A5 JP2021505527 A5 JP 2021505527A5
Authority
JP
Japan
Prior art keywords
composition
use according
omega
zeaxanthin
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020521460A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021505527A (ja
JP7824729B2 (ja
Filing date
Publication date
Priority claimed from GBGB1720119.5A external-priority patent/GB201720119D0/en
Application filed filed Critical
Publication of JP2021505527A publication Critical patent/JP2021505527A/ja
Publication of JP2021505527A5 publication Critical patent/JP2021505527A5/ja
Priority to JP2025184568A priority Critical patent/JP2026016698A/ja
Application granted granted Critical
Publication of JP7824729B2 publication Critical patent/JP7824729B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020521460A 2017-12-04 2018-05-10 神経変性疾患の予防及び/又は治療 Active JP7824729B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025184568A JP2026016698A (ja) 2017-12-04 2025-10-31 神経変性疾患の予防及び/又は治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1720119.5A GB201720119D0 (en) 2017-12-04 2017-12-04 Prevention and/or treatment of neurodegenerative disease
GB1720119.5 2017-12-04
PCT/GB2018/051255 WO2019110951A1 (en) 2017-12-04 2018-05-10 Prevention and/or treatment of neurodegenerative disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025184568A Division JP2026016698A (ja) 2017-12-04 2025-10-31 神経変性疾患の予防及び/又は治療

Publications (3)

Publication Number Publication Date
JP2021505527A JP2021505527A (ja) 2021-02-18
JP2021505527A5 true JP2021505527A5 (https=) 2021-07-26
JP7824729B2 JP7824729B2 (ja) 2026-03-05

Family

ID=60950313

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020521460A Active JP7824729B2 (ja) 2017-12-04 2018-05-10 神経変性疾患の予防及び/又は治療
JP2025184568A Pending JP2026016698A (ja) 2017-12-04 2025-10-31 神経変性疾患の予防及び/又は治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025184568A Pending JP2026016698A (ja) 2017-12-04 2025-10-31 神経変性疾患の予防及び/又は治療

Country Status (15)

Country Link
US (1) US10835509B2 (https=)
EP (2) EP4599891A3 (https=)
JP (2) JP7824729B2 (https=)
KR (1) KR20200095452A (https=)
AU (1) AU2018379644B2 (https=)
BR (1) BR112020005132A2 (https=)
CA (1) CA3071786C (https=)
ES (1) ES3047101T3 (https=)
GB (2) GB201720119D0 (https=)
IE (1) IE87241B1 (https=)
MX (1) MX2020002458A (https=)
RU (1) RU2020111305A (https=)
SG (1) SG11202000786RA (https=)
WO (1) WO2019110951A1 (https=)
ZA (1) ZA202000558B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3106957B1 (fr) * 2020-02-07 2024-05-03 Abdelhadi Zahouani Composition alimentaire pour stimuler la fonction cognitive et prevenir et limiter le declin cognitif et la demence chez des sujets adultes ou chez des sujets ages denutris
US12076299B2 (en) * 2020-02-20 2024-09-03 Arjuna Natural Pvt Ltd Composition and method to enhance cognitive support and brain health
JPWO2022244727A1 (https=) * 2021-05-17 2022-11-24
JPWO2024143060A1 (https=) * 2022-12-26 2024-07-04

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006121421A2 (en) 2004-01-14 2006-11-16 Robert Ritch Methods and formulations for treating glaucoma
US8324276B2 (en) * 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
EP2219478B1 (en) * 2007-12-17 2017-05-10 Newtricious B.V. Method of producing egg yolk based functional food product and products obtainable thereby
GB201014340D0 (en) 2010-08-27 2010-10-13 Piraee Mahmood Nutritional supplement formulation comprising saffron and resveratrol
EP3372280B1 (en) * 2011-07-07 2020-09-16 Howard Foundation Holdings Limited Improvements in or relating to visual performance
CN104619313A (zh) * 2012-07-19 2015-05-13 以瓦伦萨国际营业的美国营养品有限公司 磷虾油和反应的虾青素组合物以及相关方法
US20140187648A1 (en) * 2013-01-03 2014-07-03 Howard Foundation Holdings Ltd. Identifying Subjects in Need of Treatment
GB201300055D0 (en) * 2013-01-03 2013-02-20 Howard Foundation Holdings Ltd Identifying subjects in need of treatment
HK1211836A1 (en) * 2013-03-28 2016-06-03 Omniactive Health Technologies Limited Neuroprotective effect of carotenoids in brain
JP6375296B2 (ja) * 2013-07-10 2018-08-15 ライオン株式会社 脳機能改善用内服組成物、脳内アミロイドβ蓄積抑制用内服組成物、脳機能改善用食品組成物及び脳内アミロイドβ蓄積抑制用食品組成物
WO2017144443A1 (en) * 2016-02-22 2017-08-31 Newtricious B.V. Composition for the prevention or treatment of neurodegenerative diseases.

Similar Documents

Publication Publication Date Title
ES2826201T3 (es) Cápsulas entéricas blandas que comprenden ácidos grasos poliinsaturados
CN102843922B (zh) 硝基脂肪酸–认知减退的神经保护和/或抑制
JP2021505527A5 (https=)
CN105120872B (zh) 包含15-hepe的组合物以及其使用方法
ES2256250T3 (es) Combinaciones terapeuticas de acidos grasos.
JP2023153863A (ja) 15-hepeを含む組成物及びその使用方法
US20130108706A1 (en) Dietary formulations
JP2016053065A5 (https=)
CN103533921A (zh) 用于治疗神经外伤的方法
RU2020111305A (ru) Предупреждение и/или лечение нейродегенеративного заболевания
JP2020090508A5 (https=)
JP2023030130A5 (https=)
US20140249227A1 (en) Lipid composition for the prevention or treatment of skin problems
CN101327199A (zh) 作为抗高血压药的类胡萝卜素
ES2332102T3 (es) Composicion que contiene acidos grasos omega 3 y acidos grasos omega 6.
NZ761512B2 (en) Prevention and/or treatment of neurodegenerative disease
JP2024545117A5 (https=)
KR20050010464A (ko) 치료제
Crawford Another Supplement for CAD Prevention Fails
JP6912214B2 (ja) 赤血球機能向上剤
GB2504061A (en) Omega-6 Enriched PUFA Phospholipids
JP3249657U (ja) フィッシュオイル配合物を含むソフトカプセル構造
JP2015145421A (ja) 体重減少および肥満処置の方法
JP2017536367A5 (https=)
JP2014122210A (ja) ビタミンb1誘導体組成物